Clinical Trial Update: Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy [NA]

View source ↗

Summary

A clinical trial update examining capecitabine for breast cancer with low hormone receptor expression after neoadjuvant chemotherapy; the current status of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Breast Cancer | NA | Status: UNKNOWN